Weekly Digest – 24-30 Jun 2023 Weekly Digest – 24-30 Jun 2023 29 Jun 2023: OPDIVO (Nivolumab) / Neoadjuvant NSCLC / BMS: OPDIVO + Chemo approved in the EU The approval was based on the Phase 3 CheckMate -816 study […]
Weekly Digest – 24-30 Jun 2023 Weekly Digest – 24-30 Jun 2023 29 June 2023: RenovoGem (intra-arterial administration of gemcitabine) / RenovoRx: Reported positive interim Phase 3 data Phase 3 TIGeR-PaC study of intra-arterial gemcitabine vs. IV gemcitabine and nab-paclitaxel […]
Weekly Digest – 24-30 Jun 2023 Weekly Digest – 24-30 Jun 2023 28 Jun 2023: REQORSA (quaratusugene ozeplasmid) / extensive-stage Small Cell Lung Cancer (ES-SCLC) / Genprex: Received Fast Track Designation by the FDA REQORSA is immunogene therapy built on […]
Weekly Digest – 24-30 Jun 2023 Weekly Digest – 24-30 Jun 2023 27 Jun 2023: NOX-A12 / Glioblastoma / TME Pharma: 15 months survival data from GLORIA expansion arm Phase 1/2 GLORIA study of NOX-A12 + Irradiation in 1L Glioblastoma […]
Weekly Digest – 24-30 Jun 2023 Weekly Digest – 24-30 Jun 2023 27 Jun 2023: GAVRETO (pralsetinib) / 1L NSCLC / CStone: Approved by NMPA in China The approval was based on the positive results from the Phase 1/2 ARROW […]
